Showing results (181-190 of 9,399) with videos related to

Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|October 19, 2021
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case StudiesDonna R Rivera, Henry J Henk, Elizabeth Garrett-Mayer, et al.
Clinical Pharmacology and Therapeutics|October 21, 2021
Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation RecipientsMarita Prohn, Carolyn R Cho, Anders Viberg, et al.
Clinical Pharmacology and Therapeutics|April 1, 1986
Short-term augmented calcium intake has no effect on sodium homeostasisF C Luft, G R Aronoff, R S Sloan, et al.
Clinical Pharmacology and Therapeutics|February 8, 2022
Considerations for the Forced Expiratory Volume in 1 Second-Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug ProductsJieon Lee, Kairui Feng, Denise S Conti, et al.
Clinical Pharmacology and Therapeutics|September 1, 1986
Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrationsL Lennard, D Keen, J S Lilleyman
Clinical Pharmacology and Therapeutics|May 1, 1978
Trimethoprim/sulfamethoxazole and renal function in transplant patientsR J Caterson, P V Collett, V L Hood, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trialR A Joss, R L Galeazzi, A K Bischoff, et al.
Clinical Pharmacology and Therapeutics|April 1, 1987
Human pharmacology and abuse potential of meptazinolR E Johnson, D R Jasinski
Clinical Pharmacology and Therapeutics|January 31, 2022
Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's DiseaseSylvie Retout, Ronald Gieschke, Daniel Serafin, et al.
Clinical Pharmacology and Therapeutics|February 13, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal SymptomsRhonda M Cooper-DeHoff, Mikko Niemi, Laura B Ramsey, et al.
Pageof 940